In other tumor types, such as breast cancer [27], thyroid [16] or pancreatic cancer [28], similar sortilin expression profiles have been described, and targeting sortilin with specific pharmacological inhibitors has been shown to strongly reduce cancer cell migration and invasion. Here, SORT1 is linked to familial pancreatic carcinoma.